Royal Philips https://www.philips.com/global, has announced a strategic partnership agreement with NICO.LAB, https://nico.lab.com, a MedTech stroke care company.
Philips Image Guide Therapy System called Azurion will work with NICO.LAB’s cloud-based end-to-end AI based stroke triage and management solution, called StrokeViewer that aims to optimize stroke workflow.
StrokeViewer is able to analyze CT scan data with AI, and then automatically detect large vessel occlusion and locations. The next step is to share this analysis with physicians at both primary stroke centers and intervention centers where the patient is eventually treated.
Recently, Philips optimized the imaging capabilities of their Image Guided Therapy Angiography Suite with a new 3D visualization and measurement tool called SmartCT which aims to get patients into treatment quickly.
The SmartCT solution enriches Philips interventional tools with clear guidance, removes barriers to acquiring a 3D visualization measurement tool, which simplifies 3D visualization so that all clinical users are able to easily perform 3D imaging.
Philips is also pioneering a new approach to speeding up stroke treatment for early time window stroke patients by bypassing diagnostic CT or MR scans at certain stroke centers. In July, Philips announced their patient had been enrolled in the WE-TRUST global multicenter stroke study to assess the impact of the Direct to Angio Suite workflow in improving patient outcomes. So far, the WE-TRUST study has enrolled 564 patients at 15 sites
In addition, the Philips’ stroke portfolio includes solutions for stroke monitoring and communication in ambulances, tele-stroke patient assessments, diagnostic imaging and analysis, image-guided therapy, neurological monitoring and assessment, and more.